Autonomic modulation an emerging paradigm for the treatment of cardiovascular diseases

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 2, 2012, Pages 247-248

  Stavrakis, Stavros ^a   Scherlag, Benjamin J ^a   Po, Sunny S ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC DENERVATION; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART RATE; HUMAN; NERVE STIMULATION; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RISK; SINUS TACHYCARDIA; SYNCOPE; THROMBOEMBOLISM; ENDOCARDIUM; FEMALE; HEART ATRIUM; INNERVATION; MALE; METHODOLOGY; NOTE;

AUTONOMIC DENERVATION; ENDOCARDIUM; FEMALE; HEART ATRIA; HUMANS; MALE; SYNCOPE, VASOVAGAL;

EID: 84862244755     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.972307     Document Type: Editorial

References (20)

1. Grubb BP. Clinical practice. Neurocardiogenic syncope. N Engl J Med. 2005;352:1004-1010.
2. Brignole M. Randomized clinical trials of neurally mediated syncope. J Cardiovasc Electrophysiol. 2003;14:S64-S69.
3. Romme JJ, Reitsma JB, Black CN, Colman N, Scholten RJ, Wieling W, Van Dijk N. Drugs and pacemakers for vaso-vagal, carotid sinus and situational syncope. Cochrane Database Syst Rev. 2011;10:CD004194.
4. Yao Y, Shi R, Wong T, Zheng L, Chen W, Yang L, Huang W, Bao J, Zhang S. Endocardial autonomic denervation of the left atrium to treat vaso-vagal syncope: an early experience in human. Circ Arrhythm Electrophysiol. 2012;5:279-286.
5. Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:1186-1189.
6. Pachon JC, Pachon EI, Cunha Pachon MZ, Lobo TJ, Pachon JC, Santillana TG. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vaso-vagal) syncope: cardioneuroablation long-term results. Europace. 2011;13:1231-1242.
7. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, Trombetta I, Negrao CE, Sosa E. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation. 2006;114:876-885.
8. Hou Y, Scherlag BJ, Zhou J, Song J, Patterson E, Lazzara R, Jackman WM, Po SS. Interactive atrial neural network: determining the connections between ganglionated plexi. Heart Rhythm. 2007;4:56-63.
9. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
10. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-909.
11. Zile MR, Little WC. Effects of autonomic modulation: more than just blood pressure. J Am Coll Cardiol. 2012;59:910-912.
12. Uthman BM, Reichl AM, Dean JC, Eisenschenk S, Gilmore R, Reid S, Roper SN, Wilder BJ. Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology. 2004;63:1124-1126.
13. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32:847-855.
14. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471-1481.
15. Cavillo L, Vanoli E, Andreoli E, Besana A, Omodeo E, Gnecchi M, Zerbi P, Vago G, Busca G, Schwartz PJ. Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 2011;58:500-507.
16. Li S, Scherlag BJ, Yu L, Sheng X, Zhang Y, Ali R, Dong Y, Ghias M, Po SS. Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:645-651.
17. Yu L, Sheng X, Zhang Y, Ali R, Dong Y, Ghias M, Po SS. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455-463.
18. Sheng X, Scherlag BJ, Yu L, Li S, Ali R, Zhang Y, Fu G, Nakagawa H, Jackman WM, Lazzara R, Po SS. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol. 2011;57:563-571.
19. Shen MJ, Shinohara T, Park HW, Frick K, Ice DS, Choi EK, Han S, Maruyama M, Sharma R, Shen C, Fishbein MC, Chen LS, Lopshire JC, Zipes DP, Lin SF, Chen PS. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation. 2011;123:2204-2212.
20. Yu L, Scherlag BJ, Li S, Fan Y, Dyer J, Ghias M, Lazzara R, Po SS. Low level transcutaneous electrical stimulation suppresses atrial fibrillation (abstract). Heart Rhythm. 2011;8:S262.